Genecure - Crunchbase Company Profile & Funding

Q: Where is Genecure's headquarters?

Genecure is located in Norcross, Georgia, United States.

Q: When was the last funding round for Genecure?

Genecure closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Genecure raised to date?

Genecure has raised obfuscated.

Overview

Genecure

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Genecure

CB Rank

933874

GeneCure is a biotechnology company providing treatments for life-threatening human diseases.

Founded

obfuscation

Private

Venture - Series Unknown

Norcross, Georgia, United States

1-10

genecure.com

Biotechnology

Genetics

Health Care

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Frank Tung: CEO

Details

Legal Name

Genecure LLC

Operating Status

Active

Company Type

For Profit

Founders

Frank Tung

About the Company

GeneCure Biotechnologies is an emerging biotechnology company focused on using its novel gene transfer technology to develop treatments for life-threatening human diseases, including genetic diseases, infectious diseases, and cancers. It was founded in 1998 and headquartered in Norcross, Georgia.

Phone Number

+1 7702637508

Contact Email

info@genecure.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

HIVAX

A therapeutic HIV-1 vaccine designed to stimulate immune responses in HIV-1 positive patients, showing safety and efficacy in clinical trials.

SimVec

A gene transfer technology based on simian immunodeficiency virus, used for delivering genes into human cells for various applications including therapeutics and vaccine development.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Genecure	—	obfuscated obfuscation	—	Venture - Series Unknown